The classical biomarkers of copper metabolism (serum ceruloplasmin and copper levels, and daily urinary copper excretion) are used to establish the WD diagnosis as well as for monitoring, as described in international guidelines [1,3,36]. The gene discussed is CP; the disease is Wilson disease.